Products
Tolvagen™ Tablets
Composition
Each uncoated tablet of Tolvagen™ contains:
Tolvaptan         15 mg, 30 mg
Indications
Tolvaptan  is indicated for the treatment of clinically significant hypervolemic and euvolemic hyponatremia (serum sodium <125 mEq/L or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction), including patients with heart failure, cirrhosis, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).
Storage:
Store below 30°C;.
Keep out of reach of children.
Shelf life:
24 months
Packaging information:
15mg, 30mg x Blister pack of 10 Tablets